153 - Development of a brief overdose prevention intervention for youth in pediatric primary care
Friday, April 24, 2026
5:30pm - 8:00pm ET
Publication Number: 1143.153
Moriah N. Wiggins, Boston Medical Center, Brockton, MA, United States; Allyson G. Cogan, Boston Medical Center, Providence, RI, United States; Sarah Bagley, Boston University School of Medicine, Newton, MA, United States; Sarah Kosakowski, Boston Medical Center, Atlanta, GA, United States; Greta Schneider, Boston University, Boston, MA, United States; Kimberly M. Nelson, Boston University School of Public Health, Boston, MA, United States; Debbie Cheng, Boston University School of Public Health, Boston, MA, United States; Jessica Calihan, Mass General Brigham Hospital for Children, Boston, MA, United States; Amy Yule, Boston University School of Medicine, Boston, MA, United States
Research Coordinator Boston Medical Center Brockton, Massachusetts, United States
Background: Youth face a rising risk of fatal overdose due to an unpredictable drug supply. Primary care is an ideal setting for overdose prevention interventions, but limited guidance exist for providers to discuss these topics. Objective: Develop a brief, universal, and non-stigmatizing overdose prevention intervention for youth primary care providers, guided by a Community Advisory Board (CAB). Design/Methods: The CAB included 9 adults (healthcare professionals, family) and 6 youth (ages 13-26). Six meetings were conducted, separately, for youth and adults to amplify youth perspectives, guided by the Information Motivations and Behavior framework. Topics included opioid overdose risk behaviors, non-stigmatizing language, recognition and response to overdose, and intervention drafts. Rapid content analysis was used with standardized note-taking and recorded meetings to identify key themes and guide intervention development. Results: Five themes emerged as necessary components of the intervention: 1) Address myths/misconceptions; 2) Highlight risk from the changing drug supply and counterfeit pills; 3) Tailor language to youth (e.g., "fake pills" did not convey risk); 4) Use personal experience/storytelling instead of fear-based language; and 5) Provide handouts for content retention. Informed by these themes, we developed a 45 minute provider training and two handouts (one provider and one patient).
Conclusion(s): Through collaboration with youth, family, and healthcare professionals we developed a universal overdose prevention intervention. Next steps will be to pilot the intervention in a randomized controlled trial to assess the feasibility and acceptability in primary care settings for youth ages 13-26.